Cargando…

New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of target therapy

Association of immunotherapy and/or chemotherapy and/or targeted therapy, in sequence or as single therapies, may induce osteonecrosis of the jaw. Multidisciplinary team management of these patients should be provided.

Detalles Bibliográficos
Autores principales:	Guida, Agostino, Perri, Francesco, Ionna, Franco, Ascierto, Paolo A., Grimaldi, Antonio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813008/ https://www.ncbi.nlm.nih.gov/pubmed/33489133 http://dx.doi.org/10.1002/ccr3.3418

Ejemplares similares

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021)

Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Migliorati, Cesar Augusto
Publicado: (2022)

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022)

Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ)
por: Jowett, Adam, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report
por: Samieirad, Sahand, et al.
Publicado: (2021)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Nica, Diana Florina, et al.
Publicado: (2021)

Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study
por: Varoni, Elena M., et al.
Publicado: (2021)

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021)

Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review
por: Gkouveris, Ioannis, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
por: Rosales, Hemil Dario, et al.
Publicado: (2023)

Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset
por: Marcianò, Antonia, et al.
Publicado: (2021)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
por: Shibahara, Takahiko
Publicado: (2019)

Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
por: Okuyama, Kohei, et al.
Publicado: (2021)

Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
por: Gaudet, Camille, et al.
Publicado: (2022)

Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies
por: Muttanahally, Kavya Shankar, et al.
Publicado: (2023)

Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England
por: Sturrock, Andrew, et al.
Publicado: (2019)

New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures
por: Laimer, Johannes, et al.
Publicado: (2021)

The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)
por: Cano-Durán, Jorge A., et al.
Publicado: (2017)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
por: Al Abdullateef, Abdulrhman, et al.
Publicado: (2020)

Necrotizing periodontitis or medication-related osteonecrosis of the jaw (MRONJ) in a patient receiving Bemcentinib—a case report
por: Bumm, Caspar V., et al.
Publicado: (2020)

Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case–control study
por: Ragazzo, Mirko, et al.
Publicado: (2021)

Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
por: AlRowis, Raed, et al.
Publicado: (2022)

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)
por: Ewald, Florian, et al.
Publicado: (2020)

Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience
por: Taş Ozyurtseven, Betul, et al.
Publicado: (2021)

A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities
por: Bacci, Christian, et al.
Publicado: (2021)

Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Terms of Staging and Treatment Strategies by Dental Students at Different Educational Levels
por: Heimes, Diana, et al.
Publicado: (2023)

Platelet Rich Plasma in the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw: Personal Experience and Review of the Literature
por: Longo, F., et al.
Publicado: (2014)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
por: Dalle Carbonare, Luca, et al.
Publicado: (2021)

Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement
por: Sánchez-Gallego Albertos, Celia, et al.
Publicado: (2021)

Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing
por: Kim, Songmi, et al.
Publicado: (2022)

Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study
por: Jamalpour, Mohammad Reza, et al.
Publicado: (2022)

The use of advanced‐platelet rich fibrin (A‐PRF) in the management of medication‐related osteonecrosis of the jaw (MRONJ): A case report
por: Asfour, Maan Ahmad Rafik, et al.
Publicado: (2023)

Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study
por: Tenore, Gianluca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69eofltd7g3dqrmd0g4g057sbk